Contents |
Description |
Note |
Overview
|
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths in the world. Current curative therapies for HCC include resection, transplantation, RFA or MWA. |
|
Features
|
RFA/MWA is a curative treatment for HCC. Radiofrequency/microwave is generated from the needle, and heat was stimulated to destroy tumors. |
|
Procedure
|
Before the procedure, sedative medications and analgesic are given. The RFA/MWA needle, guided by either sonography or computed tomography, will be inserted into target tumors. Radiofrequency will be generated to destroy the lesions. |
|
Notification
|
Potential risks and complications include: . Bleeding . Infection . Biliary tract injury, e.g. biliary stricture, biloma . Liver failure . Pneumothorax . Skin burn . Tract seeding . Vascular damage, including portal vein thrombosis, hepatic vein thrombosis, pseudoaneurysm . Visceral damage |
|
Estimated Cost
|
For estimated medical costs, please contact International Medical Services Center. |
|
Date: day /month/year
Note: The information collected in this questionnaire will be used as a guide for International Medical Service on IMSC’s Website.
Contact number: 2785-7808
Email: imsc@vghtpe.gov.tw
Last Modified: